Founded in 2016, TrueBinding Inc. is a clinical-stage biotherapeutic company researching and developing first-in-class monoclonal antibody drugs to treat Dementia and Alzheimer's Disease (AD).
| Website | http://www.truebinding.com |
| Revenue | $8.5 million |
| Employees | 34 (30 on RocketReach) |
| Founded | 2016 |
| Address | 300 Lincoln Center Drive 200, Foster City, California 94404, US |
| Industry | Biotechnology Research |
| Keywords | Biotherapeutics, Monoclonal Antibodies, Dementia Treatment, Clinical Stage, Drug Development, Biotechnology, Pharmaceutical Research, Neurodegenerative Diseases, Antibody Drugs, Therapeutic Antibodies, Clinical Trials, Disease Treatment, Protein Therapeutics, Immunotherapy, Biologics, Drug Discovery |
| Competitors | Canva, Down Syndrome Association of Central NJ, Vistaprint SAR.L., Zazzle, Printful, MOO, Lulu Press, Inc., Blurb, Snapfish, Gooten +37 more (view full list) |
Looking for a particular TrueBinding employee's phone or email?
The TrueBinding annual revenue was $8.5 million in 2026.
Dongxu Sun is the CEO of TrueBinding.
30 people are employed at TrueBinding.
TrueBinding is based in Foster City, California.